131 related articles for article (PubMed ID: 33756412)
41. Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.
Jiang H; Li C; Yin P; Guo T; Liu L; Xia L; Wu Y; Zhou F; Ai L; Shi W; Lu X; Wang H; Tang L; Wei Q; Deng J; Jin R; Xiong W; Dong J; Mei H; Hu Y
Am J Hematol; 2019 Oct; 94(10):1113-1122. PubMed ID: 31321805
[TBL] [Abstract][Full Text] [Related]
42. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
[TBL] [Abstract][Full Text] [Related]
43. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M
Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389
[TBL] [Abstract][Full Text] [Related]
44. Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio.
Nagant C; Casula D; Janssens A; Nguyen VTP; Cantinieaux B
Int J Lab Hematol; 2018 Dec; 40(6):734-739. PubMed ID: 30113764
[TBL] [Abstract][Full Text] [Related]
45. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
47. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
Caldwell CW; Patterson WP
Am J Hematol; 1991 Feb; 36(2):111-5. PubMed ID: 1849347
[TBL] [Abstract][Full Text] [Related]
48. ZAP-70 as a possible prognostic factor in childhood acute lymphoblastic leukemia.
Ebeid E; Kamel M; Moussa H; Galal U
J Egypt Natl Canc Inst; 2008 Jun; 20(2):121-6. PubMed ID: 20029467
[TBL] [Abstract][Full Text] [Related]
49. A case of CD45-, CD19- precursor B cell acute lymphoblastic leukemia with an atypical morphology.
Moon H; Huh J; Cho MS; Chi H; Chung WS
Korean J Lab Med; 2007 Aug; 27(4):253-6. PubMed ID: 18094585
[TBL] [Abstract][Full Text] [Related]
50. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
51. Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.
Yang L; Dao FT; Lu AD; Chen WM; Li LD; Long LY; Liu YR; Liu KY; Zhang LP; Qin YZ
Pediatr Hematol Oncol; 2022 Mar; 39(2):97-107. PubMed ID: 34156313
[TBL] [Abstract][Full Text] [Related]
52. [Loss of CD45 expression at relapse of acute myeloid leukemia].
Yamamoto K; Yakushijin K; Kurata K; Mizutani Y; Inui Y; Uryu K; Kawamoto S; Sugimoto T; Matsuoka H; Minami H
Rinsho Ketsueki; 2017; 58(8):938-941. PubMed ID: 28883278
[TBL] [Abstract][Full Text] [Related]
53. Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.
Mussolin L; Buldini B; Lovisa F; Carraro E; Disarò S; Lo Nigro L; d'Amore ES; Pillon M; Basso G
Pediatr Blood Cancer; 2015 Nov; 62(11):1906-13. PubMed ID: 26109265
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
55. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
56. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
57. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Shuster JJ; Falletta JM; Pullen DJ; Crist WM; Humphrey GB; Dowell BL; Wharam MD; Borowitz M
Blood; 1990 Jan; 75(1):166-73. PubMed ID: 1688495
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Willoughby M
Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
[TBL] [Abstract][Full Text] [Related]
60. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
